Cargando…

Adding genetic scores to risk models in colorectal cancer

Detalles Bibliográficos
Autores principales:	Gargallo-Puyuelo, Carla J., Lanas, Ángel, Asunción García-Gonzalez, María
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690674/ https://www.ncbi.nlm.nih.gov/pubmed/31448048 http://dx.doi.org/10.18632/oncotarget.27110

Ejemplares similares

Familial Colorectal Cancer and Genetic Susceptibility: Colorectal Risk Variants in First-Degree Relatives of Patients With Colorectal Cancer
por: Gargallo-Puyuelo, Carla J., et al.
Publicado: (2021)

Genetic susceptibility in the development of colorectal adenomas according to family history of colorectal cancer
por: Gargallo, Carla J., et al.
Publicado: (2018)

Importance of adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment
por: Gargallo, Carla J., et al.
Publicado: (2013)

Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage
por: Sostres, Carlos, et al.
Publicado: (2013)

Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?
por: Gargallo-Puyuelo, Carla J., et al.
Publicado: (2021)

How to Choose the Biologic Therapy in a Bio-naïve Patient with Inflammatory Bowel Disease
por: Laredo, Viviana, et al.
Publicado: (2022)

Small and Large Intestine (II): Inflammatory Bowel Disease, Short Bowel Syndrome, and Malignant Tumors of the Digestive Tract
por: Ber, Yolanda, et al.
Publicado: (2021)

Risk of Cancer in Patients with Inflammatory Bowel Diseases and Keys for Patient Management
por: Laredo, Viviana, et al.
Publicado: (2023)

Iron Treatment May Be Difficult in Inflammatory Diseases: Inflammatory Bowel Disease as a Paradigm
por: Gargallo-Puyuelo, Carla J., et al.
Publicado: (2018)

Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits
por: Lué, Alberto, et al.
Publicado: (2016)

Risk of Advanced Neoplasia in First-Degree Relatives with Colorectal Cancer: A Large Multicenter Cross-Sectional Study
por: Quintero, Enrique, et al.
Publicado: (2016)

Determining the role of genetic risk scores in symptomatic cancer detection
por: Bailey, Sarah ER, et al.
Publicado: (2023)

Deconvolution Analysis for Classifying Gastric Adenocarcinoma Patients Based on Differential Scanning Calorimetry Serum Thermograms
por: Vega, Sonia, et al.
Publicado: (2015)

CagA-positive Helicobacter pylori infection is not associated with decreased risk of Barrett's esophagus in a population with high H. pylori infection rate
por: Ferrández, Angel, et al.
Publicado: (2006)

Genetic Risk Score, Combined Lifestyle Factors and Risk of Colorectal Cancer
por: Cho, Young Ae, et al.
Publicado: (2019)

Colorectal cancer population screening programs worldwide in 2016: An update
por: Navarro, Mercedes, et al.
Publicado: (2017)

A colorectal cancer prediction model using traditional and genetic risk scores in Koreans
por: Jung, Keum Ji, et al.
Publicado: (2015)

AINE y riesgo digestivo
por: Marcén, Beatriz, et al.
Publicado: (2016)

The impact of COVID-19 pandemic in the diagnosis and management of colorectal cancer patients
por: Domper-Arnal, María José, et al.
Publicado: (2022)

Head-to-Head Comparison of Family History of Colorectal Cancer and a Genetic Risk Score for Colorectal Cancer Risk Stratification
por: Weigl, Korbinian, et al.
Publicado: (2019)

Can Genetic Risk Scoring Predict Atrial Fibrillation Ablation Outcomes?
por: Lin, Chin-Yu, et al.
Publicado: (2019)

New use of low-dose aspirin and risk of colorectal cancer by stage at diagnosis: a nested case–control study in UK general practice
por: García Rodríguez, Luis A., et al.
Publicado: (2017)

Can molecular biomarkers replace a clinical risk score for resectable colorectal liver metastasis?
por: Veen, Torhild, et al.
Publicado: (2017)

The added value of genetic information in colorectal cancer risk prediction models: development and evaluation in the UK Biobank prospective cohort study
por: Smith, Todd, et al.
Publicado: (2018)

Clinical, Experimental, and Modeling Studies in AD/HD
por: Sonuga-Barke, Edmund J. S., et al.
Publicado: (2004)

Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel disease
por: Refaie, Engy, et al.
Publicado: (2022)

Impact of the lockdown period due to the COVID-19 pandemic in patients with inflammatory bowel disease
por: Refaie, Engy, et al.
Publicado: (2022)

Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score
por: Weigl, Korbinian, et al.
Publicado: (2018)

Liver Fibrosis in Non-Alcoholic Fatty Liver Disease and Progression to Hepatocellular Carcinoma in Patients with Inflammatory Bowel Disease: A Systematic Review
por: Martínez-Domínguez, Samuel J., et al.
Publicado: (2023)

Value added by an inter-continental cancer consortium
por: Rao, Mahadev, et al.
Publicado: (2021)

Blood-Cell-Based Inflammatory Markers as a Useful Tool for Early Diagnosis in Colorectal Cancer
por: Hernandez-Ainsa, Maria, et al.
Publicado: (2022)

An Added Strength
Publicado: (1900)

Metformin and Colorectal Cancer Risk in Diabetic Patients
por: Ioannou, George N., et al.
Publicado: (2011)

Risk of colorectal cancer in patients with diverticular disease
por: Meyer, Jeremy, et al.
Publicado: (2018)

How to Enhance Dental Implant Therapies and Definitive Restoration Outcomes to Reduce Complications and Improve Patient Well-Being
por: Gargallo-Albiol, Jordi
Publicado: (2023)

Lifestyle Can Exert a Significant Impact on the Development of Metabolic Complications and Quality Life in Patients with Inflammatory Bowel Disease
por: García-Mateo, Sandra, et al.
Publicado: (2023)

Do we need biomarkers to predict the benefit of adding adjuvant taxanes for treatment of breast cancer?
por: Pérez-García, José, et al.
Publicado: (2012)

Biochemistry: Production of High-Added Value Biomolecules for Industrial Uses
por: Karra-Chaabouni, Maha, et al.
Publicado: (2018)

Polygenic risk score across distinct colorectal cancer screening outcomes: from premalignant polyps to colorectal cancer
por: Obón-Santacana, Mireia, et al.
Publicado: (2021)

Antitumor effects of lactate transport inhibition on esophageal adenocarcinoma cells
por: Grasa, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lg8r4a8dr2pu64bq6m6mnge812